Glossary
Ingrid U. Scott, MD, MPH and Harry W. Flynn, Jr., MD
Chapter 1: Medical Overview of the Worldwide Diabetes Epidemic
Robert E. Leonard II, MD and David W. Parke II, MD
Chapter 2: Classification of Diabetic Retinopathy
Charles P. Wilkinson, MD
Chapter 3: Histopathological Manifestations of Diabetic Retinopathy
Matthew Guess, MD and Sander R. Dubovy, MD
Chapter 4: Pathogenesis of Diabetic Retinopathy
Thomas W. Gardner, MD, MS and Lloyd Paul Aiello, MD, PhD
Chapter 5: Epidemiology and Risk Factors of Diabetic Retinopathy
Tien Y. Wong, MD, PhD, Ronald Klein, MD, MPH, and Barbara E. K. Klein, MD, MPH
Chapter 6: History of Evolving Treatments for Diabetic Retinopathy
George W. Blankenship, MD
Chapter 7: Photography, Angiography, and Ultrasonography in Diabetic Retinopathy
Andrew Lam, MD, Nicholas G. Anderson, MD, Carl D. Regillo, MD, and Gary C. Brown, MD, MBA
Chapter 8: Optical Coherence Tomography in the Management of Diabetic Retinopathy
Andrew A. Moshfeghi, MD, Ingrid U. Scott, MD, MPH, Harry W. Flynn, Jr., MD, and Carmen A. Puliafito, MD, MBA
Chapter 9: Clinical Studies on Treatment for Diabetic Retinopathy
Frederick L. Ferris III, MD, Matthew D. Davis, MD, Lloyd M. Aiello, MD, and Emily Y. Chew, MD
Chapter 10: Photocoagulation for Diabetic Macular Edema and Diabetic Retinopathy
Mitchell J. Goff, MD, H. Richard McDonald, MD, and Everett Ai, MD
Chapter 11: Vitrectomy for Diabetic Retinopathy
William E. Smiddy, MD and Harry W. Flynn, Jr., MD
Chapter 12: Intravitreal Pharmacotherapies for Diabetic Retinopathy
Sophie J. Bakri, MD and Peter K. Kaiser, MD
Chapter 13: Evolving Algorithms for Managing Diabetic Macular Edema
Diana V. Do, MD and Julia A. Haller, MD
Chapter 14: Management of Diabetic Retinopathy: Evidence-based Systematic Review
Quresh Mohamed, MD, Mark C. Gillies, MD, PhD, and Tien Y. Wong, MD, PhD
Chapter 15: Cataract Management in Diabetes
Mitchell S. Fineman, MD, William E. Benson, MD, Ingrid U. Scott, MD, MPH
Chapter 16: Nonretinal Ocular Abnormalities in Diabetes
Ingrid U. Scott, MD, MPH and Harry W. Flynn, Jr., MD
Chapter 17: The Effect of Systemic Conditions on Diabetic Retinopathy
Emily Y. Chew, MD
Chapter 18: Medical Management of the Diabetic Patient
Jay S. Skyler, MD
Chapter 19: Telemedicine for Diabetic Retinopathy
Helen K. Li, MD and Matthew T. S. Tennant, MD
Chapter 20: Future Therapies: Rationale for and Status of Anti-angiogenic and Anti-permeability Interventions
Nigel H. Timothy, MD, Jennifer K. Sun, MD, Jerry Cavallerano, OD, PhD, Thomas W. Gardner, MD, MS, and Lloyd Paul Aiello, MD, PhD
Appendix: Abstracts of Major Collaborative Multicenter Trials for Diabetic Retinopathy
Compiled by Nauman A. Chaudhry, MD, Ingrid U. Scott, MD, MPH, and Harry W. Flynn, Jr., MD
Index
